| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.68 | 0.01 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.6 | 0.06 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.39 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.29 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.2 | 0.5 |